ProShares Ultra Semiconductors (USD)

NYSEARCA: USD · Real-Time Price · USD
92.56
-8.09 (-8.04%)
At close: Jun 26, 2026, 4:00 PM EDT
93.00
+0.44 (0.48%)
After-hours: Jun 26, 2026, 6:54 PM EDT
-8.04%
Assets $2.63B
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 30.12M
Dividend (ttm) $0.30
Dividend Yield 0.33%
Ex-Dividend Date Jun 24, 2026
Payout Ratio n/a
1-Year Return +160.92%
Volume 793,954
Open 94.97
Previous Close 100.65
Day's Range 92.23 - 96.86
52-Week Low 34.43
52-Week High 116.50
Beta 3.66
Holdings 51
Inception Date Jan 30, 2007

About USD

Fund Home Page

The ProShares Ultra Semiconductors (USD) is an exchange-traded fund that is based on the Dow Jones U.S. Semiconductors index. The fund provides 2x exposure to a market-cap-weighted index that tracks the performance of large US semiconductor companies. USD was launched on Jan 30, 2007 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol USD
ETF Provider ProShares
Index Tracked Dow Jones U.S. Semiconductors Index

Top 10 Holdings

184.01% of assets
Name Symbol Weight
DJ U.S. SEMICONDUCTORS INDEX SWAP UBS AG n/a 26.83%
DJ U.S. SEMICONDUCTORS INDEX SWAP BANK OF AMERICA NA n/a 25.03%
DJ U.S. SEMICONDUCTORS INDEX SWAP CITIBANK NA n/a 23.59%
DJ U.S. SEMICONDUCTORS INDEX SWAP BNP PARIBAS n/a 23.37%
DJ U.S. SEMICONDUCTORS INDEX SWAP SOCIETE GENERALE n/a 19.50%
DJ U.S. SEMICONDUCTORS INDEX SWAP JPMORGAN CHASE BANK NA n/a 17.15%
DJUSSC SWAP GOLDMAN SACHS INTERNATIONAL n/a 16.64%
DJ U.S. SEMICONDUCTORS INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC n/a 16.25%
NVIDIA Corporation NVDA 11.38%
Broadcom Inc. AVGO 4.27%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jun 24, 2026 $0.14275 Jun 30, 2026
Mar 25, 2026 $0.05874 Mar 31, 2026
Dec 24, 2025 $0.08129 Dec 31, 2025
Sep 24, 2025 $0.02072 Sep 30, 2025
Jun 25, 2025 $0.08021 Jul 1, 2025
Mar 26, 2025 $0.02493 Apr 1, 2025
Full Dividend History

News

There's never been a semiconductor rally like this one — and that's triggering a number of warnings

Parabolic moves in the market ‘only end one way,' says BTIG's Krinsky

2 months ago - Market Watch

Wi2Wi Corporation Announces Full Year 2025 Financial Results

Company Shows Improved Gross Margin and Continued Focus on Future Revenue Growth TORONTO, ON / ACCESS Newswire / April 10, 2026 / Wi2Wi Corporation (TSXV:YTY)(OTC PINK:ISEYF) a leader in precision tim...

2 months ago - Accesswire

Fujifilm to Present Latest Advanced Lithography Research at SPIE Advanced Lithography + Patterning 2026 Conference

TOKYO--(BUSINESS WIRE)--FUJIFILM Corporation will present the company's latest research findings at SPIE Advanced Lithography + Patterning 2026 (SPIE 2026), taking place February 22-26, 2026, in San J...

4 months ago - Business Wire

Wi2Wi Corporation Announces Third Quarter 2025 Financial Results and Leadership Transition

TORONTO, ON / ACCESS Newswire / November 18, 2025 / Wi2Wi Corporation (TSX-V:YTY)(OTC:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announce...

7 months ago - Accesswire

McFarlane Lake Announces Closing of Final Tranche Of $9.34 Million Equity Financing

TORONTO, ON / ACCESS Newswire / October 10, 2025 / McFarlane Lake Mining Limited (CSE:MLM)(OTCQB:MLMLF) ("McFarlane Lake" or the "Company"), a Canadian gold exploration and development company, is ple...

9 months ago - Accesswire

McFarlane Issues NI 43-101 Mineral Resource Estimate on Its Juby Gold Project

Highlights of Mineral Resource estimate 3.17 million inferred ounces gold at 0.89 gram per tonne (gpt or g/t) gold 1.01 million indicated ounces gold at 0.98 gpt gold using long term gold price of US$...

9 months ago - Accesswire

Wi2Wi Corporation Announces Second Quarter 2025 Financial Results

TORONTO, ON / ACCESS Newswire / August 15, 2025 / Wi2Wi Corporation (TSXV:YTY)(OTC PINK:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announ...

11 months ago - Accesswire

Idaho Strategic Reports Record Second Quarter Operating and Financial Performance

Highlighted by a 54.71% Increase in Revenue to $9,476,739 - a New Quarterly Revenue Record, and the Completion of 5,819 Meters of Drilling COEUR D'ALENE, ID / ACCESS Newswire / August 7, 2025 / Idaho ...

Other symbols: IDR
11 months ago - Accesswire

Wi2Wi Corporation Announces First Quarter 2025 Financial Results (Unaudited)

TORONTO, ON / ACCESS Newswire / May 16, 2025 / Wi2Wi Corporation (TSX-V:YTY)(OTC PINK:ISEYF) a leader in precision timing devices, frequency control products, and wireless technologies, today announce...

1 year ago - Accesswire

Idaho Strategic Reports First Quarter 2025 Operating and Financial Performance

Highlighted by a 23.39% Increase in Revenue to $7,278,536 - a New Quarterly Revenue Record, and the Completion of 4,230 Meters of Drilling at the Golden Chest Mine COEUR D'ALENE, ID / ACCESS Newswire ...

Other symbols: IDR
1 year ago - Accesswire

VeriSign Inc falls -10.0%

VeriSign Inc (USD) is down -10.0%, or -$3.83 to $34.51.

1 year ago - TheFly

VeriSign Inc falls -8.7%

VeriSign Inc (USD) is down -8.7%, or -$3.33 to $35.00.

1 year ago - TheFly

VeriSign Inc falls -9.6%

VeriSign Inc (USD) is down -9.6%, or -$3.69 to $34.65.

1 year ago - TheFly

VeriSign Inc falls -10.4%

VeriSign Inc (USD) is down -10.4%, or -$4.27 to $36.97.

1 year ago - TheFly

VeriSign Inc falls -10.5%

VeriSign Inc (USD) is down -10.5%, or -$4.31 to $36.93.

1 year ago - TheFly

Idaho Strategic Reports Record Operating and Financial Performance for 2024

Annual Revenue Increased 88.66%, While Annual Net Income Increased 663.27% Ended 2024 With Cash and Investments in US Treasury Notes Totaling $16,091,024 Achieved Nine Consecutive Quarters of GAAP Pro...

Other symbols: IDR
1 year ago - Accesswire

CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes

This Press Release updates numerical list in reference section Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of t...

1 year ago - Accesswire

Theralase(R) Demonstrates Effective Treatment of Herpes

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ACCES...

1 year ago - Accesswire

AI-themed ETFs plunge in wake of DeepSeek news

Prices of exchange-traded funds with outsize exposure to Nvidia plunged in the initial hours of trading on Monday in reaction to news that a Chinese startup has launched a powerful new artificial inte...

Other symbols: AISNVDLVGT
1 year ago - Reuters

VeriSign Inc falls -20.8%

VeriSign Inc (USD) is down -20.8%, or -$15.13 to $57.69.

1 year ago - TheFly

VeriSign Inc falls -4.7%

VeriSign Inc (USD) is down -4.7%, or -$3.24 to $65.04.

1 year ago - TheFly

Worldwide Hardcopy Peripherals Shipments Increased 3.8% Year Over Year in The Third Quarter of 2024, According to IDC

NEEDHAM, Mass.--(BUSINESS WIRE)-- #BROTHER--The global HCP market rebounded in the third quarter of 2024, achieving a 3.8% year-over-year (YoY) growth to approximately 20.3 million units shipped in., ...

1 year ago - Business Wire

Idaho Strategic Reports Third Quarter 2024 Operating and Financial Performance

Highlighted by an 86.39% Increase in Revenue and a 376.44% Increase in Net Income - IDR Continued its Strong Financial Performance Despite Increased Exploration Expense Leading to the Discovery of the...

Other symbols: IDR
1 year ago - Accesswire

Idaho Strategic Reports Second Quarter 2024 Operating and Financial Performance

Highlighted by an 89.26% Increase in Revenue and a 558.30% Increase in Net Income - IDR's 6-Month Net Income in 2024 is Nearly 4x Last Year's Total Net Income COEUR D'ALENE, ID / ACCESSWIRE / July 30,...

Other symbols: IDR
2 years ago - Accesswire

Rutherrin(R) Repurposes Non-Cancer Drugs for Cancer Therapy

TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and d...

2 years ago - Accesswire